Products and Services

OINDP specialist CDMOs Bespak and Upperton have announced a new strategic collaboration that will offer Upperton nasal drug development services including formulation and clinical manufacturing capability, in conjunction with Bespak nasal delivery devices. Upperton introduced… Read more . . .

Drug delivery specialist Zeteo Biomedical has announced the availability of its first device for delivery to the lung, the AriesMR DPI, which the company describes as “a reloadable active dry powder inhaler designed for controlled… Read more . . .

Aptar Pharma will provide nasal delivery technology for a project led by Massachusetts General Hospital Assistant Professor Alice Stanton to develop a platform designed to improve development of therapies intended for nose-to-brain delivery. The company… Read more . . .

Aptar Pharma has announced a deal with French biotech Aceso Therapeutics related to development of Aceso’s ACT-101 antisense oligonucleotide for the treatment of cystic fibrosis. According to Aptar, its subsidiary Nanopharm will provide development services… Read more . . .

Inhaler testing specialist Copley Scientific has announced the launch of its new Inhalytix+ v2.0 and Critical Flow Controller TPK 200iX. The company launched  Version 1 of Inhalytix+, a subscription-based cascade impactor software package, in August 2025. The TPK… Read more . . .

Drug delivery specialist Nemera has announced the launch of a new bidose nasal spray platform called DuoSpray that is intended for delivery of systemic drugs, including CNS therapies. The company says that the customizable intranasal… Read more . . .

Inhalation specialist CDMO Bespak announced that its Holmes Chapel, UK site has again received a Gold EcoVadis sustainability rating, the second since Bespak was spun out from Recipharm in 2024. Earlier this year, Bespak and… Read more . . .

According to Aptar Pharma, parent company of OINDP-focused CRO Nanopharm, the UK Medicines and Healthcare Products Regulatory Agency has completed an inspection of Nanopharm’s facility in Cwmbran, Wales and has certified the location as GMP compliant.… Read more . . .

According to Texas-based CDMO Matica Biotechnology, the company will provide development and manufacturing services to vaccine developer VaxDome, also based in Texas, to advance a VaxDome intranasal antiviral / vaccine candidate into clinical trials. Matica… Read more . . .